Quantum Biopharma (QNTM) Operating Expenses (2019 - 2026)

Quantum Biopharma (QNTM) has 8 years of Operating Expenses data on file, last reported at $3.0 million in Q1 2026.

• Quarterly Operating Expenses fell 12.69% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.9 million (up 11.88% YoY) and the FY2025 annual result came in at $15.3 million, down 5.17% from the prior year.
• Operating Expenses advanced to $3.0 million in Q1 2026 per QNTM's latest filing, from $2.4 million in the prior quarter.
• The five-year high for Operating Expenses was $9.8 million in Q1 2023, with the low at $1.9 million in Q2 2023.
• Average Operating Expenses over 5 years is $3.9 million, with a median of $3.4 million recorded in 2025.
• The widest YoY moves for Operating Expenses: up 84.77% in 2024, down 77.07% in 2024.
• Quantum Biopharma's Operating Expenses stood at $5.6 million in 2022, then sank by 41.38% to $3.3 million in 2023, then tumbled by 31.84% to $2.3 million in 2024, then advanced by 5.14% to $2.4 million in 2025, then gained by 24.98% to $3.0 million in 2026.
• Business Quant data shows QNTM's Operating Expenses at $3.0 million in Q1 2026, $2.4 million in Q4 2025, and $4.7 million in Q3 2025.